Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2003
03/13/2003US20030049274 PRRSV vaccines
03/13/2003US20030049273 Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
03/13/2003US20030049271 Diagnosis, therapy of bacteria infections
03/13/2003US20030049266 Induce immunology response usin gpolynucleotide
03/13/2003US20030049265 Heliobacter pylori antigen
03/13/2003US20030049251 Methods and compositions useful for inhibiting ccr5-dependent infection of cells by hiv-1
03/13/2003US20030049240 Pet food composition for treating helicobacter species in pets
03/13/2003US20030049231 Therapy for skin disorders; human or veterinary medicine
03/13/2003US20030049229 Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
03/13/2003US20030049208 For delivering a medicant; product includes a coating having a medicament or agent; bioavailabilty; chewing gum product that releases caffiene for improved performance
03/13/2003US20030049203 Targeted nucleic acid constructs and uses related thereto
03/13/2003DE3890874C2 Rekombinante Viren Recombinant viruses
03/13/2003CA2459492A1 Anti-influenzal agent
03/13/2003CA2459348A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
03/13/2003CA2459045A1 Antidiabetic extracts of artemisia dracunculus
03/13/2003CA2458926A1 Methods of treating infection by drug resistant bacteria
03/13/2003CA2458876A1 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
03/13/2003CA2458820A1 Agent for suppression of hepatitis b virus replication
03/13/2003CA2458807A1 Use of atazanavir in hiv therapy
03/13/2003CA2458780A1 Targeted nucleic acid constructs and uses related thereto
03/13/2003CA2458644A1 Crystaline clindamycin free base
03/13/2003CA2458093A1 Urea and thiourea derivatives as non-nucleoside reverse transcriptase inhibitors
03/13/2003CA2457861A1 Piperidine derivatives useful as ccr5 antagonists
03/13/2003CA2457520A1 Modified transferrin fusion proteins
03/13/2003CA2456904A1 Aerosolized decongestants for the treatment of sinusitis
03/13/2003CA2454413A1 7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors
03/13/2003CA2452438A1 4-thioxo-4,7-dihydro-thieno¬2,3-b|pyridine-5-carbothioamides as antiviral agents
03/13/2003CA2452431A1 4-thioxo-4,7-dihydro-thieno¬2,3-b|pyridine-5-carboxamides as antiviral agents
03/12/2003EP1291437A1 New assay for inhibitors of translocases
03/12/2003EP1291430A1 Ceramide kinase and dna encoding the same
03/12/2003EP1291423A1 Polyfunctional base sequence and artificial gene containing the same
03/12/2003EP1291360A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
03/12/2003EP1291353A1 6-O-substituted ketolides having antibacterial activity
03/12/2003EP1291352A1 6-O-substituted ketolides having antibacterial activity
03/12/2003EP1291351A1 6-0 substituted ketolides having antibacterial activity
03/12/2003EP1291350A1 6-0 substituted ketolides having antibacterial activity
03/12/2003EP1291346A1 Process for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties
03/12/2003EP1291019A1 Biologically active agents and drugs
03/12/2003EP1291015A1 Dosage forms having prolonged active ingredient release
03/12/2003EP1290231A1 Two-hybrid assay that detects hiv-1 reverse transcriptase dimerization
03/12/2003EP1290227A1 Compositions, kits, and methods for identification and modulation of type i diabetes
03/12/2003EP1290214A2 Inhibiting retroviral integration by targeting the atm pathway
03/12/2003EP1290204A1 Antisense modulation of c/ebp alpha expression
03/12/2003EP1290193A2 Protein phosphatases
03/12/2003EP1290187A2 Humain kinases
03/12/2003EP1290180A2 Drug metabolizing enzymes
03/12/2003EP1290170A2 Binding agents: chimeric ligand/receptor proteins
03/12/2003EP1290161A1 METHODS FOR MEDIATING GENE SUPPRESION BY USING FACTORS THAT ENHANCE RNAi
03/12/2003EP1290154A2 The identification and use of effectors and allosteric molecules for the alteration of gene expression
03/12/2003EP1290140A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof
03/12/2003EP1290136A1 Novel probiotics for pet food applications
03/12/2003EP1290027A2 Immunoadhesin for the prevention of rhinovirus infection
03/12/2003EP1290020A1 Peptide substrate identified by type bont/b botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors
03/12/2003EP1290019A2 Use of coiled-coil structural scaffold to generate structure-specific peptides
03/12/2003EP1290018A2 Convergent combinatory peptide libraries and their use for vaccination against hepatitis c virus
03/12/2003EP1290017A2 Compositions and methods for delivery of a molecule into a cell
03/12/2003EP1290016A2 Vaccine for congenital tremors in pigs
03/12/2003EP1290013A2 Apo-ai/aii peptide derivatives
03/12/2003EP1290010A1 Pyridine-2-yl-aminoalkyl carbonyl glycyl-$g(b)-alanine and derivatives thereof
03/12/2003EP1290006A1 Combinatorial production of nucleotide and nucleoside (xitp)analogues
03/12/2003EP1289998A1 New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives
03/12/2003EP1289993A1 Caspase inhibitors and uses thereof
03/12/2003EP1289984A1 Novel oxazolidinone derivatives and a process for the preparation thereof
03/12/2003EP1289980A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
03/12/2003EP1289959A1 Dihydrostilbene alkanoic acid derivatives useful as vitronectin antagonists
03/12/2003EP1289958A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a)
03/12/2003EP1289957A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
03/12/2003EP1289956A1 Chemical compounds
03/12/2003EP1289951A1 Growth hormone secretagogues
03/12/2003EP1289913A1 Novel antibiotic compounds
03/12/2003EP1289564A2 T cell receptor fusions and conjugates and methods of use thereof
03/12/2003EP1289550A1 Chlamydial glycolipid vaccines
03/12/2003EP1289549A2 The use of plant oil-bodies in vaccine delivery systems
03/12/2003EP1289548A2 Immune system stimulating means
03/12/2003EP1289547A2 Immunization through oral administration of a vaccine with an edible product
03/12/2003EP1289543A2 Formulations and methods for treating hypercoagulable states
03/12/2003EP1289541A2 Interferon for the treatment of multiple sclerosis
03/12/2003EP1289525A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
03/12/2003EP1289511A1 Bactericidal preparation
03/12/2003EP1289495A1 Process for the preparation of a sterile ointment containing acyclovir
03/12/2003EP1289494A2 Powder compositions
03/12/2003EP1289479A1 Hair oils
03/12/2003EP1103252B1 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method
03/12/2003EP1097127B1 Diacylhydrazine derivatives as integrin inhibitors
03/12/2003EP0991415B1 Orally administrable solid ribavirin dosage forms and process for making them
03/12/2003EP0970098B1 Anthracycline glycosides
03/12/2003EP0884950B1 A method of killing or inhibiting microbial cells
03/12/2003EP0881886B1 Animal feed
03/12/2003EP0845984B1 Use of aminoadamantane compounds as immunoregulators
03/12/2003EP0811067B1 Equine arteritis virus peptides, antibodies and their use in a diagnostic test
03/12/2003EP0781095B1 Cells bearing cd4 decoy receptors and related molecules and methods
03/12/2003EP0763039B1 42-rapamycin hydroxyester, process for its preparation and pharmaceutical compositions containing it
03/12/2003EP0672031B1 Catechol diethers as selective pde iv inhibitors
03/12/2003CN1402797A Compositions and methods for preventing transepithelial transmission of HIV
03/12/2003CN1402786A Production of complex carbohydrates
03/12/2003CN1402785A Novel compounds
03/12/2003CN1402780A 感染性克隆 Infectious clone
03/12/2003CN1402733A Angiogenic proteins and uses thereof
03/12/2003CN1402724A Thiazolidinedione derivs. as antidiabetic agents
03/12/2003CN1402711A 4-carboxyamino-2-ethyl-1,2,3,4-tetrahydroquinoline crystal as CETP inhibitor
1 ... 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 ... 1798